1. Surveillance of Diversion and Nonmedical Use of Extended-Release Prescription Amphetamine and Oral Methylphenidate in the United States
- Author
-
Mark A. Sembower, Nabarun Dasgupta, Michelle D. Ertischek, Sidney H. Schnoll, and Chloe Buchholtz
- Subjects
Adult ,medicine.medical_specialty ,Poison Control Centers ,Prescription Drug Misuse ,Adolescent ,Databases, Factual ,Amphetamine-Related Disorders ,amphetamine ,Medicine (miscellaneous) ,Poison control ,Pharmacy ,methylphenidate ,Drug Prescriptions ,psychostimulants ,Medicine ,Attention deficit hyperactivity disorder ,Humans ,Medical prescription ,substance abuse and dependence ,Practice Patterns, Physicians' ,Amphetamine ,Psychiatry ,Child ,Pharmacies ,business.industry ,Methylphenidate ,General Medicine ,Drug diversion ,respiratory system ,medicine.disease ,United States ,Psychiatry and Mental health ,Clinical Psychology ,Attention Deficit Disorder with Hyperactivity ,Child, Preschool ,Delayed-Action Preparations ,Drug and Narcotic Control ,Central Nervous System Stimulants ,Attention-deficit hyperactivity disorder ,business ,human activities ,medicine.drug ,Research Article - Abstract
This article examines rates of nonmedical use and diversion of extended-release amphetamine and extended-release oral methylphenidate in the United States. Prescription dispensing data were sourced from retail pharmacies. Nonmedical use data were collected from the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) System Drug Diversion Program and Poison Center Program. Drug diversion trends nearly overlapped for extended-release amphetamine and extended-release oral methylphenidate. Calls to poison centers were generally similar; however, calls regarding extended-release amphetamine trended slightly lower than those for extended-release oral methylphenidate. Data suggest similar diversion and poison center call rates for extended-release amphetamine and extended-release oral methylphenidate.
- Published
- 2013